Efficacy of Cryptdin-2 as an Adjunct to Antibiotics from Various Generations Against Salmonella

Indian Journal of Microbiology

Volumn 54, Issue 3, 2014, Pages 323-328

  Singh, Aman Preet ^a   Prabha, Vijay ^a   Rishi, Praveen ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Conventional antibiotics; FBC; Salmonella; Synergy; Time kill assay

Indexed keywords

EID: 84901845417     PISSN: 00468991     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12088-014-0463-y     Document Type: Article

References (27)

1. Haraga A, Ohlson MB, Miller SI (2008) Salmonellae interplay with host cells. Nat Rev Microbiol 6: 53-66.
2. Singh AP, Preet S, Rishi P (2011) Augmentation of antimicrobial activity of conventional antibiotics by cell free extract of L. plantarum. J Antibiot 64: 795-798.
3. Chalon MC, Acuña L, Morero RD, Minahk CJ, Bellomio A (2012) Membrane-active bacteriocins to control Salmonella in foods: are they the definite hurdle? Food Res Int 45: 735-744.
4. Wiradharma N, Khoe U, Hauser CA, Seow SV, Yang YY, Zhang S (2011) Synthetic cationic amphiphilic α-helical peptides as antimicrobial agents. Biomaterials 32: 2204-2212.
5. Marr AK, Gooderham WJ, Hancock RE (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6: 468-472.
6. Mastroianni JR, Ouellette AJ (2009) α-Defensins in enteric innate immunity: functional Paneth cell α-defensins in mouse colonic lumen. J Biol Chem 284: 27848-27856.
7. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ (2000) Secretion of microbicidal α-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 1: 113-118.
8. Hancock REW, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24: 1551-1557.
9. Masuda K, Sakai N, Nakamura K, Yoshioka S, Ayabe T (2010) Bactericidal activity of mouse α-defensin cryptdin-4 predominantly affects noncommensal bacteria. J Innate Immun 3: 315-326.
10. Preet S, Rishi P (2010) Antimicrobial activity of Paneth-cell derived cryptdin-2 against selected pathogens. Am J Biomed Sci 2: 13-22.
11. Foureau DM, Mielcarz DW, Menard LC et al (2010) TLR9-dependent induction of intestinal alpha-defensins by Toxoplasma gondii. J Immunol 184: 7022-7029.
12. Tanabe H, Ouellette AJ, Cocco MJ, Robinson WE (2004) Differential effects on human immunodeficiency virus type 1 replication by α-defensins with comparable bactericidal activities. J Virol 78: 11622-11631.
13. Cassone M, Otvos L Jr (2010) Synergy among antibacterial peptides and between peptides and small-molecule antibiotics. Expert Rev Anti Infect Ther 8: 703-716.
14. Giacometti A, Cirioni O, Barchiesi F, Fortuna M, Scalise G (1999) In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa. J Antimicrob Chemother 44: 641-645.
15. Yenugu S, Narmadha G (2010) The human male reproductive tract antimicrobial peptides of the HE2 family exhibit potent synergy with standard antibiotics. J Pept Sci 16: 337-341.
16. Preet S, Verma I, Rishi P (2010) Cryptdin-2: a novel therapeutic agent for experimental Salmonella typhimurium infection. J Antimicrob Chemother 65: 991-994.
17. Rishi P, Preet S, Bharrhan S, Verma I (2011) In-vitro and in vivo synergistic effects of cryptdin 2 and ampicillin against Salmonella. Antimicrob Agents Chemother 55: 4176-4182.
18. Rishi P, Preet S, Kaur P (2011) Effect of L. plantarum cell-free extract and co-trimoxazole against Salmonella typhimurium: a possible adjunct therapy. Ann Clin Microbiol Antimicrob 10: 9.
19. Birosova L, Mikulasova M (2009) Development of triclosan and antibiotic resistance in Salmonella enterica serovar typhimurium. J Med Microbiol 58: 436-441.
20. Mandal S, Mandal MD, Pal NK (2004) Synergism of ciprofloxacin and trimethoprim against Salmonella enterica serovar typhi isolates showing reduced susceptibility to ciprofloxacin. Chemotherapy 50: 152-154.
21. Aarestrup FM, Wiuff C, Molbak K, Threlfall EJ (2003) Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob Agents Chemother 47: 827-829.
22. Fey PD, Safranek TJ, Rupp ME et al (2000) Ceftriaxone-resistant Salmonella infection acquired by a child from cattle. N Engl J Med 342: 1242-1249.
23. Endt K, Maier L, Käppeli R, Barthel M, Misselwitz B, Kremer M, Hardt WD (2012) Peroral ciprofloxacin therapy impairs the generation of a protective immune response in a mouse model for Salmonella enterica serovar Typhimurium diarrhea, while parenteral ceftriaxone therapy does not. Antimicrob Agents Chemother 56: 2295-2304.
24. Lencer WI, Cheung G, Strohmeier GR, Currie MG, Ouellette AJ, Selsted ME, Madara JL (1997) Induction of epithelial chloride secretion by channel-forming cryptdins-2 and 3. Proc Natl Acad Sci USA 94: 8585-8589.
25. Campos MA, Morey P, Bengoechea JA (2006) Quinolones sensitize Gram-negative bacteria to antimicrobial peptides. Antimicrob Agents Chemother 50: 2361-2367.
26. Darveau RP, Cunningham MD, Seachord CL, Cassiano-Clough L, Cosand WL, Blake J, Watkins CS (1991) Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob Agents Chemother 35: 1153-1159.
27. Ulvatne H, Karoliussen S, Stiberg T, Rekdal O, Svendsen JS (2001) Short antibacterial peptides and erythromycin act synergically against Escherichia coli. J Antimicrob Chemother 48: 203-208.